The UCL and University of Houston spinout has raised more than $22m to date and is commercialising magnetic surgical guidance devices for breast cancer procedures.
Endomag, a UK-based surgical guidance technology spinout of University College London and University of Houston, received $10m today in a series C round led by VC firm Draper Esprit.
Founded in 2007, Endomag develops surgical guidance tools for breast cancer procedures that rely on magnetic sensors to improve accuracy, efficiency, workflow and accessibility in the operating theatre.
The company’s product range includes a handheld detection device called Sentimag that can help clinicians identify sentinel lymph nodes, the medical term for…
